Bottom line
What is RYAPX's expense ratio?
RYAPX's expense ratio is 1.7%, or about $170 a year on every $10,000 invested. That is more expensive than 87% of leveraged & inverse funds we track (median 1.31%). This share class also charges a front-end sales load of up to 4.75%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Jul 29, 2026
RYAPX fee table
| Net expense ratio | 1.7% |
|---|---|
| Gross expense ratio | 1.81% |
| Management fee | 0.9% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.64% |
| Acquired fund fees | 0.02% |
| Fee waiver / reimbursement | -0.11% |
| Max front-end sales load | 4.75% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Jul 29, 2026
What RYAPX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| RYAPX | $640 | $1,007 | $1,399 | $2,492 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.7% expense ratio costs roughly $88,600 in lost growth, versus about $70,600 for the median leveraged & inverse fund (1.31%).